Emamectin benzoate treatment alters the expression and activity of CYP1A, FMO and GST in different tissues of rainbow trout (Oncorhynchus mykiss)

dc.date.accessioned2020-03-11T20:31:38Z
dc.date.accessioned2022-10-18T22:51:54Z
dc.date.available2020-03-11T20:31:38Z
dc.date.available2022-10-18T22:51:54Z
dc.date.created2020-03-11T20:31:38Z
dc.date.issued2014
dc.identifierhttp://hdl.handle.net/10533/239472
dc.identifier15110027
dc.identifierWOS:000345058700027
dc.identifierno scielo
dc.identifiereid=2-s2.0-84906751225
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4470811
dc.description.abstractEmamectin benzoate (EMB) is one of the drugs used for the treatment and control of infections by Caligus rogercresseyi on salmonids. EMB is orally delivered to the salmon in food, which could be affecting the activity of biotransformation markers in these
dc.languageeng
dc.relationhttps://doi.org/10.1016/j.aquaculture.2014.08.014
dc.relation10.1016/j.aquaculture.2014.08.014
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.titleEmamectin benzoate treatment alters the expression and activity of CYP1A, FMO and GST in different tissues of rainbow trout (Oncorhynchus mykiss)
dc.typeArticulo


Este ítem pertenece a la siguiente institución